126.50
+2.00
+(1.61%)
At close: 11:03:44 AM GMT+8
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
341,760.00
415,130.00
277,484.00
336,498.00
220,200.00
Investing Cash Flow
-111,107.00
-93,677.00
-585,046.00
-336,075.00
-272,061.00
Financing Cash Flow
-324,183.00
-200,537.00
238,750.00
-108,875.00
-43,992.00
End Cash Position
227,440.00
366,891.00
246,053.00
314,801.00
423,417.00
Capital Expenditure
-90,940.00
-93,801.00
-584,712.00
-61,669.00
-272,754.00
Issuance of Debt
296,583.00
386,493.00
792,000.00
100,000.00
235,000.00
Repayment of Debt
-470,763.00
-436,493.00
-430,000.00
-100,000.00
-185,000.00
Free Cash Flow
250,820.00
321,329.00
-307,228.00
274,829.00
-52,554.00
12/31/2020 - 11/14/2014
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
1777.TWO SYN-TECH Chem. & Pharm. Co., Ltd.
92.00
-0.11%
6662.TWO BioLASCO Taiwan Co., Ltd.
34.00
+3.03%
3118.TWO Level Biotechnology Inc.
32.25
-0.31%
4728.TWO Sunmax Biotechnology Co., Ltd.
272.50
-0.91%
6492.TWO Senhwa Biosciences, Inc.
42.00
-0.83%
4162.TWO PharmaEngine, Inc.
93.20
-2.00%
6461.TWO Intech Biopharm Corporation
24.50
-1.41%
6712.TWO Ever Supreme Bio Technology Co., Ltd
175.50
0.00%
4911.TWO G&E Herbal Biotechnology Co., Ltd.
54.40
-0.55%
6733.TWO BioGend Therapeutics Co., Ltd.
32.80
-0.61%